Engineered Monoclonal Antibody VYD222 Potently Neutralizes Broad SARS-CoV-2 Variants
A structural analysis reveals how the engineered antibody VYD222 overcomes spike mutations to neutralize diverse SARS-CoV-2 variants.
A structural analysis reveals how the engineered antibody VYD222 overcomes spike mutations to neutralize diverse SARS-CoV-2 variants.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.